Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

NCT00533390 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

130

Enrollment

OTHER

Sponsor class

Stopped Lack of financial support and low inclusion rate

Conditions

Tuberculosis
HIV Infections

Interventions

DRUG: efavirenz

Sponsor

Oswaldo Cruz Foundation

Collaborators

[object Object]